Who Owns CNS PHARMACEUTICALS INC (CNSP)? -- Institutional Holders (2026-06-30)

15 institutions reported holding $1.3M of CNS PHARMACEUTICALS INC (CNSP) in SEC 13F filings for 2026-06-30. Largest institutional holders: Ikarian Capital, LLC ($649,267), ADAR1 Capital Management, LLC ($334,600), Stonepine Capital Management, LLC ($198,719), VANGUARD GROUP INC ($82,307), BOOTHBAY FUND MANAGEMENT, LLC ($64,645). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1Ikarian Capital, LLC$649,267135,830Added
2ADAR1 Capital Management, LLC$334,60070,000New
3Stonepine Capital Management, LLC$198,71941,573Trimmed
4VANGUARD GROUP INC$82,30717,219New
5BOOTHBAY FUND MANAGEMENT, LLC$64,64513,524Hold
6UBS Group AG$6,9831,461Added
7Tower Research Capital LLC (TRC)$3,819799Trimmed
8BARCLAYS PLC$9119New
9BARRETT & COMPANY, INC.$388Hold
10DANSKE BANK A/S$51Hold
11MAI Capital Management$00Exited
12Caitong International Asset Management Co., Ltd$00Exited
13GEODE CAPITAL MANAGEMENT, LLC$00Exited
14Sound Income Strategies, LLC$00Exited
15CITIGROUP INC$00Exited

Source: SEC Form 13F filings · as of 2026-06-30